Keeping the environment in mind!

A new plan for Teva api to contribute to the reduction of CO2 emissions by 15% by 2020, compared to our 2012 baseline in TEVA.

Teva api is planning to achieve energy efficiencies through investment in engineering improvements, energy management systems, adopting new technologies, and applying “Energy by Design” principles to seek energy savings in every project.

We continue to consider opportunities to source renewable energy and establish cogeneration or green energy production where possible. As part of these improvements, we are initiating a plan to minimize refrigerants gas leak and eliminate R-22 refrigerant in our equipment.

Reducing emissions: In our Opava factory in the Czech Republic, we made a change that saves more than 3,000 metric tons of greenhouse gas emissions per year. In 2014, we installed a condensing economizer to increase the efficiency and utilization of natural gas, the basic source of energy for the central steam boiler room at the site. Utilizing the condensing heat of water, which is produced during the combustion of natural gas, significantly increases the efficiency of the boilers and reduces our natural gas consumption.

 

Reducing waste: In our Villanterio site in Italy, we manufacture the active pharmaceutical ingredient allopurinol that is used to prevent the buildup of uric acid in the body to prevent liver or kidney diseases.

The allopurinol process yields different types of waste. Following detailed analysis of the waste streams, we improved the process by segregating process elements, increasing recovery of solvents and installing new equipment. As a result, we increased the yield of active ingredient by 2.4% and reduced the total unrecovered waste generated through this process.

For more information about Teva api’s EHS topics, please contact us.

As a division of Teva Pharmaceutical Industries Ltd., Teva api is committed to Teva’s global approach to community giving, which encourages employees around the world to make a difference in their communities. Teva api’s employees proudly participate through volunteerism and donations that support local causes.

Teva’s Global Approach

Teva is committed to improving global healthcare by enhancing access to medicines and contributing to the well-being of communities in which we live and operate. We support thousands of employees who volunteer in their communities in multiple ways.

Teva focuses community engagement efforts on:

  • Enhancing access to affordable medicines, health and well-being
  • Promoting science and science education
  • Responding to local needs

Investment and involvement in local communities is an essential part of Teva’s corporate social responsibility. At many Teva api sites around the world, employees spearhead community involvement projects based on local needs through:

  • Partnerships with local leading non-profit organizations to advance social causes, supported by specific community solidarity activities.
  • Volunteering in the communities where Teva api employees live and work. We encourage employees worldwide to donate their time and expertise to deepen our relationship with patients and communities.
  • Donations to projects worldwide that improve health and well-being, support science education and other community needs.

Read more about Teva’s global approach to community giving.

Teva api is committed to business practices that promote social and environmental responsible economic growth. We believe that everyone has the right to a healthy and safe work environment.

We earn the right to operate by being effective stewards of the environment, and with a commitment that all injuries, incidents and releases are preventable.  Compliance is at the foundation of our operations, and our EHS Management System takes our performance beyond compliance.

Teva api is on a journey to Target Zero, i.e., no injuries, illness, or releases, where  continuous effort is applied to reduce the emissions of greenhouse pollutants and volatile organic compounds (VOCs).Teams of experts work to design and redesign our operations to reduce, reuse and recycle materials, which is good for the environment and reduces our cost of goods. Teva api has sophisticated control equipment to manage air emissions and wastewater.

Teva api is a division of Teva Pharmaceutical Industries Ltd., the global generic pharmaceutical leader and one of the world’s top 15 pharmaceutical companies. Read more about Teva’s ongoing commitment to the environment.

A discussion with Teva experts on why ESG makes a difference

The World of the API is a podcast series by Teva api. In this series, we explore the stories of the work we do at Teva api, through conversations with the scientists, leaders and experts who make it happen.

In episode #3, we have a chat with Teva Environmental, Social, Governance (ESG) experts, Itamar Schwartz and Adam Ajzensztejn about ESG in pharma. We talk about why ESG is such a buzz word at the moment, what impact the pharma industry can actually have, and what makes Teva’s recent $5 billion sustainability-linked bond the first of its kind.

Discover the podcast on

Watch this space for more episodes of the The World of the API podcast.

Contact us

Step 1 of

    First name*
    Last name*
    Business email*
    Company*
    Job title*
    Country*
    I'm interested in*
    Segment of interest*
    Tell us more about your project
    Select product*
    Formulation
    Project type*
    Target market
    Quantity
    Comments
    Disclaimer: This material might be protected by exclusive rights such as patents and/or supplementary protection certificates or extensions in certain jurisdictions, and therefore might not be available for specific countries. TAPI will only be able to offer and supply this pharmaceutical ingredient in the countries and exclusively for uses that are exempt from infringement of such exclusive rights in accordance with applicable law. TAPI requires adequate confirmation of the exempt use upon ordering.
    By clicking submit, you are agreeing to our Privacy Policy